AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $86,000 | -69.2% | 1,871 | -63.0% | 0.01% | -61.5% |
| Q2 2021 | $279,000 | +9200.0% | 5,061 | +7933.3% | 0.01% | – |
| Q1 2021 | $3,000 | 0.0% | 63 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | +50.0% | 63 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -75.0% | 63 | -61.8% | 0.00% | -100.0% |
| Q2 2020 | $8,000 | +33.3% | 165 | -5.7% | 0.00% | – |
| Q1 2020 | $6,000 | -14.3% | 175 | +17.4% | 0.00% | – |
| Q4 2019 | $7,000 | +75.0% | 149 | +10.4% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 135 | +164.7% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 51 | -19.0% | 0.00% | – |
| Q2 2017 | $3,000 | -40.0% | 63 | -30.8% | 0.00% | – |
| Q1 2017 | $5,000 | -44.4% | 91 | -47.1% | 0.00% | -100.0% |
| Q3 2016 | $9,000 | – | 172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |